The US market for neurovascular devices will grow strongly through 2027 as a result of the adoption of innovative devices as well as the ongoing expansion of dedicated infrastructure for neurovascular interventions. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for stroke devices in the US across a 10-year period

The results of the ASTER trial triggered the incorporation of aspiration thrombectomy into guidelines as a first-line treatment for AIS.

How will the updated guidelines impact market growth?

What barriers continue to affect uptake of aspiration thrombectomy?

How significantly are cost concerns impacting neurovascular thrombectomy device choice in the US market?

A number of companies are launching new neurovascular devices in the US market.

How strongly will competition increase in market segments that were previously monopolized by a single competitor? 

What tactics are smaller companies using to gain share in the market?

How does the competitive landscape in the US differ from other global neurovascular device markets?

The initial results of the HEAT trial demonstrated the superiority of hydrogel-coated embolization coils in comparison to bare platinum coils.

How dramatically will these results impact the use of coated and bare platinum coils? What role will cost play in device uptake?

Which companies will benefit from these favorable results, and which companies will be negatively impacted?

Table of contents

  • Neurovascular Devices - Market Insights - United States

Author(s): Ashish Bhupal, MBA

Ashish Bhupal is a manager within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in clot management, vascular access, aortic repair, heart valve, structural heart, interventional oncology, peripheral vascular, neurovascular, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor's in Biotechnology and an MBA in Biotechnology Management from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution.

Follow Ashish on Twitter: @Ashishb_DRG.

Related Reports

Heart Valve Devices - Market Insights - Latin America

The Latin American heart valve device market will experience strong growth through 2029, largely driven by an expanding patient pool, improving...

View Details

Dialysis Access Treatment Devices - Market Insights - Europe

The European market for dialysis access treatment devices is a dynamic market that will grow moderately through 2029, driven by the availability of novel and innovative products. However, market re...

View Details

Dialysis Access Treatment Devices - Market Insights - Asia Pacific

The Asia Pacific dialysis access treatment device market will grow modestly through 2029, driven by rising incidence of

View Details

Cardiac Rhythm Management Devices - Market Insights - Japan

The mature Japanese CRM device market will remain flat through 2029, characterized by low generator unit volume growth, rising

View Details